Molecular Diagnostics for Cancer. Markets, Strategies and Trends. Forecasts by Cancer Type, including companion Dx and by Country. With Executive and Consultant Guides and COVID pandemic recession forecast revisions. 2020 to 2024
“Companion Diagnostics and Liquid Biopsy drive market growth while lowering costs. COVID causes resources shift....
334 pages packed with information
A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report from Howe Sound Research. We include a special segment Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations. Trends like
- personalized medicine
- liquid biopsy
- emergence of new economies with large markets
- greater understanding of the role of genetic material in Disease and Health
Working against this dynamic market are the forces of the COVID Driven Recession. Our latest numbers factor in the different COVID forces and their timing. And their effect on growth.
Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
In addition customization work, breakouts for particular segments, assistance and support is included free of charge with every report.
" Molecular Diagnostics for Cancer. Markets, Strategies and Trends. Forecasts by Cancer Type, including companion Dx and by Country. With Executive and Consultant Guides and COVID pandemic recession forecast revisions. 2020 to 2024" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help understand test pricing in detail. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.
Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
See the Table of Contents.
Send an email to us at email@example.com and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part. And we will not pester you with phone calls!
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research.
He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research - Burke Institute
Finance for Senior Executives - Harvard Business School